Personal information

No personal information available

Activities

Works (26)

The Role of Sociodemographics in Pediatric, Adolescent and Young Adult Osteosarcoma: A Population Based Study

Journal of Pediatric Surgery
2025-04 | Journal article
Contributors: Connor Fritz; Anthony Basta; Jonathan Gill; Valerae Lewis; Justin Bird; Mary Austin
Source: check_circle
Crossref

Data from ABBV-085, Antibody–Drug Conjugate Targeting LRRC15, Is Effective in Osteosarcoma: A Report by the Pediatric Preclinical Testing Consortium

2023-04-03 | Preprint
Contributors: Pooja Hingorani; Michael E. Roth; Yifei Wang; Wendong Zhang; Jonathan B. Gill; Douglas J. Harrison; Beverly Teicher; Stephen Erickson; Gregory Gatto; Malcolm A. Smith et al.
Source: check_circle
Crossref

Data from ABBV-085, Antibody–Drug Conjugate Targeting LRRC15, Is Effective in Osteosarcoma: A Report by the Pediatric Preclinical Testing Consortium

2023-04-03 | Preprint
Contributors: Pooja Hingorani; Michael E. Roth; Yifei Wang; Wendong Zhang; Jonathan B. Gill; Douglas J. Harrison; Beverly Teicher; Stephen Erickson; Gregory Gatto; Malcolm A. Smith et al.
Source: check_circle
Crossref

Data from Comprehensive Surfaceome Profiling to Identify and Validate Novel Cell-Surface Targets in Osteosarcoma

2023-04-03 | Preprint
Contributors: Yifei Wang; Xiangjun Tian; Wendong Zhang; Zhongting Zhang; Rossana Lazcano; Pooja Hingorani; Michael E. Roth; Jonathan D. Gill; Douglas J. Harrison; Zhaohui Xu et al.
Source: check_circle
Crossref

Data from Comprehensive Surfaceome Profiling to Identify and Validate Novel Cell-Surface Targets in Osteosarcoma

2023-04-03 | Preprint
Contributors: Yifei Wang; Xiangjun Tian; Wendong Zhang; Zhongting Zhang; Rossana Lazcano; Pooja Hingorani; Michael E. Roth; Jonathan D. Gill; Douglas J. Harrison; Zhaohui Xu et al.
Source: check_circle
Crossref

Supplementary Data from ABBV-085, Antibody–Drug Conjugate Targeting LRRC15, Is Effective in Osteosarcoma: A Report by the Pediatric Preclinical Testing Consortium

2023-04-03 | Preprint
Contributors: Pooja Hingorani; Michael E. Roth; Yifei Wang; Wendong Zhang; Jonathan B. Gill; Douglas J. Harrison; Beverly Teicher; Stephen Erickson; Gregory Gatto; Malcolm A. Smith et al.
Source: check_circle
Crossref

Supplementary Data from ABBV-085, Antibody–Drug Conjugate Targeting LRRC15, Is Effective in Osteosarcoma: A Report by the Pediatric Preclinical Testing Consortium

2023-04-03 | Preprint
Contributors: Pooja Hingorani; Michael E. Roth; Yifei Wang; Wendong Zhang; Jonathan B. Gill; Douglas J. Harrison; Beverly Teicher; Stephen Erickson; Gregory Gatto; Malcolm A. Smith et al.
Source: check_circle
Crossref

Supplementary Data from ABBV-085, Antibody–Drug Conjugate Targeting LRRC15, Is Effective in Osteosarcoma: A Report by the Pediatric Preclinical Testing Consortium

2023-04-03 | Preprint
Contributors: Pooja Hingorani; Michael E. Roth; Yifei Wang; Wendong Zhang; Jonathan B. Gill; Douglas J. Harrison; Beverly Teicher; Stephen Erickson; Gregory Gatto; Malcolm A. Smith et al.
Source: check_circle
Crossref

Supplementary Data from ABBV-085, Antibody–Drug Conjugate Targeting LRRC15, Is Effective in Osteosarcoma: A Report by the Pediatric Preclinical Testing Consortium

2023-04-03 | Preprint
Contributors: Pooja Hingorani; Michael E. Roth; Yifei Wang; Wendong Zhang; Jonathan B. Gill; Douglas J. Harrison; Beverly Teicher; Stephen Erickson; Gregory Gatto; Malcolm A. Smith et al.
Source: check_circle
Crossref

Supplementary Data from Comprehensive Surfaceome Profiling to Identify and Validate Novel Cell-Surface Targets in Osteosarcoma

2023-04-03 | Preprint
Contributors: Yifei Wang; Xiangjun Tian; Wendong Zhang; Zhongting Zhang; Rossana Lazcano; Pooja Hingorani; Michael E. Roth; Jonathan D. Gill; Douglas J. Harrison; Zhaohui Xu et al.
Source: check_circle
Crossref

Supplementary Data from Comprehensive Surfaceome Profiling to Identify and Validate Novel Cell-Surface Targets in Osteosarcoma

2023-04-03 | Preprint
Contributors: Yifei Wang; Xiangjun Tian; Wendong Zhang; Zhongting Zhang; Rossana Lazcano; Pooja Hingorani; Michael E. Roth; Jonathan D. Gill; Douglas J. Harrison; Zhaohui Xu et al.
Source: check_circle
Crossref

Supplementary Figure from Comprehensive Surfaceome Profiling to Identify and Validate Novel Cell-Surface Targets in Osteosarcoma

2023-04-03 | Preprint
Contributors: Yifei Wang; Xiangjun Tian; Wendong Zhang; Zhongting Zhang; Rossana Lazcano; Pooja Hingorani; Michael E. Roth; Jonathan D. Gill; Douglas J. Harrison; Zhaohui Xu et al.
Source: check_circle
Crossref

Supplementary Figure from Comprehensive Surfaceome Profiling to Identify and Validate Novel Cell-Surface Targets in Osteosarcoma

2023-04-03 | Preprint
Contributors: Yifei Wang; Xiangjun Tian; Wendong Zhang; Zhongting Zhang; Rossana Lazcano; Pooja Hingorani; Michael E. Roth; Jonathan D. Gill; Douglas J. Harrison; Zhaohui Xu et al.
Source: check_circle
Crossref

Evaluation of the pan‐class I phosphoinositide 3‐kinase (PI3K) inhibitor copanlisib in the Pediatric Preclinical Testing Consortium in vivo models of osteosarcoma

Pediatric Blood & Cancer
2023-01 | Journal article
Contributors: Douglas Harrison; Jonathan Gill; Michael Roth; Pooja Hingorani; Wendong Zhang; Beverly Teicher; Eric Earley; Stephen Erickson; Gregory Gatto; Raushan Kurmasheva et al.
Source: check_circle
Crossref

Author Correction: Osteosarcoma

Nature Reviews Disease Primers
2022-12-30 | Journal article
Contributors: Hannah C. Beird; Stefan S. Bielack; Adrienne M. Flanagan; Jonathan Gill; Dominique Heymann; Katherine A. Janeway; J. Andrew Livingston; Ryan D. Roberts; Sandra J. Strauss; Richard Gorlick
Source: check_circle
Crossref

Osteosarcoma

Nature Reviews Disease Primers
2022-12-08 | Journal article
Contributors: Hannah C. Beird; Stefan S. Bielack; Adrienne M. Flanagan; Jonathan Gill; Dominique Heymann; Katherine A. Janeway; J. Andrew Livingston; Ryan D. Roberts; Sandra J. Strauss; Richard Gorlick
Source: check_circle
Crossref

Trastuzumab Deruxtecan, Antibody–Drug Conjugate Targeting HER2, Is Effective in Pediatric Malignancies: A Report by the Pediatric Preclinical Testing Consortium

Molecular Cancer Therapeutics
2022-08-02 | Journal article
Contributors: Pooja Hingorani; Wendong Zhang; Zhongting Zhang; Zhaohui Xu; Wei-Lien Wang; Michael E. Roth; Yifei Wang; Jonathan B. Gill; Douglas J. Harrison; Beverly A. Teicher et al.
Source: check_circle
Crossref

Comprehensive Surfaceome Profiling to Identify and Validate Novel Cell-Surface Targets in Osteosarcoma

Molecular Cancer Therapeutics
2022-06-01 | Journal article
Contributors: Yifei Wang; Xiangjun Tian; Wendong Zhang; Zhongting Zhang; Rossana Lazcano; Pooja Hingorani; Michael E. Roth; Jonathan D. Gill; Douglas J. Harrison; Zhaohui Xu et al.
Source: check_circle
Crossref

Advancing therapy for osteosarcoma

Nature Reviews Clinical Oncology
2021-10 | Journal article
Contributors: Jonathan Gill; Richard Gorlick
Source: check_circle
Crossref

ABBV-085, Antibody–Drug Conjugate Targeting LRRC15, Is Effective in Osteosarcoma: A Report by the Pediatric Preclinical Testing Consortium

Molecular Cancer Therapeutics
2021-03-01 | Journal article
Contributors: Pooja Hingorani; Michael E. Roth; Yifei Wang; Wendong Zhang; Jonathan B. Gill; Douglas J. Harrison; Beverly Teicher; Stephen Erickson; Gregory Gatto; Malcolm A. Smith et al.
Source: check_circle
Crossref

Survey of Paediatric Oncologists and Pathologists regarding Their Views and Experiences with Variant Translocations in Ewing and Ewing-Like Sarcoma: A Report of the Children’s Oncology Group

Sarcoma
2020-12-04 | Journal article
Contributors: Michael D. Kinnaman; Chong Zhu; Daniel A. Weiser; Sana Mohiuddin; Pooja Hingorani; Michael Roth; Jonathan Gill; Katherine A. Janeway; Richard Gorlick; Stephen L. Lessnick et al.
Source: check_circle
Crossref

Dose‐response effect of eribulin in preclinical models of osteosarcoma by the pediatric preclinical testing consortium

Pediatric Blood & Cancer
2020-10 | Journal article
Contributors: Jonathan Gill; Wendong Zhang; Zhongting Zhang; Michael Roth; Douglas J. Harrison; Sudie Rowshan; Stephen Erickson; Gregory Gatto; Raushan Kurmasheva; Peter Houghton et al.
Source: check_circle
Crossref

Initial in vivo testing of a multitarget kinase inhibitor, regorafenib, by the Pediatric Preclinical Testing Consortium

Pediatric Blood & Cancer
2020-06 | Journal article
Contributors: Douglas J. Harrison; Jonathan D. Gill; Michael E. Roth; Wendong Zhang; Beverly Teicher; Stephen Erickson; Greg Gatto; Raushan T. Kurmasheva; Peter J. Houghton; Malcolm A. Smith et al.
Source: check_circle
Crossref

High-Dose Chemotherapy with Stem Cell Rescue in Desmoplastic Small Round Cell Tumor: A Single-Institution Experience and Review of the Literature

Sarcoma
2018 | Journal article
Contributors: Kayleen Bailey; Michael Roth; Daniel Weiser; Jonathan Gill
Source: check_circle
Crossref

A phase I window, dose escalating and safety trial of metformin in combination with induction chemotherapy in relapsed refractory acute lymphoblastic leukemia: Metformin with induction chemotherapy of vincristine, dexamethasone, PEG‐asparaginase, and doxorubicin

Pediatric Blood & Cancer
2018-09 | Journal article
Contributors: Matteo Trucco; Julio C. Barredo; John Goldberg; Gilles M. Leclerc; Gregory A. Hale; Jonathan Gill; Bhuvana Setty; Tiffany Smith; Richard Lush; Jae K. Lee et al.
Source: check_circle
Crossref

Pediatric oncologist willingness to offer germline TP53 testing in osteosarcoma

Cancer
2018-03-15 | Journal article
Contributors: Eliana Shaul; Michael Roth; Yungtai Lo; David S. Geller; Bang Hoang; Rui Yang; David Malkin; Richard Gorlick; Jonathan Gill
Source: check_circle
Crossref

Peer review (1 review for 1 publication/grant)

Review activity for Journal of the National Cancer Institute : (1)